Taysha Gene Therapies, Inc.
TSHA
$2.31
-$0.07-2.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 116.59M | 139.04M | 157.69M | 172.74M | 123.98M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.06M | 1.36M | 1.87M | 969.00K | 1.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.05M | 1.73M | 2.00M | 4.76M | 5.20M |
| Total Current Assets | 120.71M | 142.13M | 161.56M | 178.47M | 130.60M |
|
|
|||||
| Total Current Assets | 120.71M | 142.13M | 161.56M | 178.47M | 130.60M |
| Net Property, Plant & Equipment | 15.32M | 15.87M | 16.29M | 19.48M | 19.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.34M | 2.37M | 2.37M | 2.44M | 2.46M |
| Total Assets | 138.36M | 160.36M | 180.22M | 200.39M | 153.00M |
|
|
|||||
| Total Accounts Payable | 4.33M | 3.59M | 4.93M | 8.72M | 10.38M |
| Total Accrued Expenses | 7.81M | 9.59M | 9.40M | 8.75M | 10.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81M | 1.88M | 1.82M | 1.75M | 1.70M |
| Total Finance Division Other Current Liabilities | 8.61M | 11.17M | 13.19M | 14.96M | 16.27M |
| Total Other Current Liabilities | 8.61M | 11.17M | 13.19M | 14.96M | 16.27M |
| Total Current Liabilities | 22.56M | 26.23M | 29.34M | 34.18M | 38.64M |
|
|
|||||
| Total Current Liabilities | 22.56M | 26.23M | 29.34M | 34.18M | 38.64M |
| Long-Term Debt | 42.45M | 43.94M | 42.97M | 37.84M | 40.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.37M | 17.74M | 18.23M | 18.71M | 19.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 925.00K | 930.00K | 882.00K | 800.00K | 826.00K |
| Total Liabilities | 83.30M | 88.84M | 91.42M | 91.53M | 99.15M |
|
|
|||||
| Common Stock & APIC | 681.18M | 677.86M | 674.65M | 664.46M | 591.17M |
| Retained Earnings | -623.83M | -602.31M | -583.52M | -558.00M | -537.07M |
| Treasury Stock & Other | -2.29M | -4.03M | -2.33M | 2.41M | -251.00K |
| Total Common Equity | 55.06M | 71.53M | 88.80M | 108.87M | 53.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.06M | 71.53M | 88.80M | 108.87M | 53.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.06M | 71.53M | 88.80M | 108.87M | 53.85M |
|
|
|||||